Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eastman Chemical (EMN) Change in Account Payables (2016 - 2025)

Historic Change in Account Payables for Eastman Chemical (EMN) over the last 17 years, with Q4 2025 value amounting to $199.0 million.

  • Eastman Chemical's Change in Account Payables rose 3092.11% to $199.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$76.0 million, marking a year-over-year decrease of 14042.55%. This contributed to the annual value of -$76.0 million for FY2025, which is 14042.55% down from last year.
  • As of Q4 2025, Eastman Chemical's Change in Account Payables stood at $199.0 million, which was up 3092.11% from -$120.0 million recorded in Q3 2025.
  • Over the past 5 years, Eastman Chemical's Change in Account Payables peaked at $199.0 million during Q4 2025, and registered a low of -$158.0 million during Q2 2023.
  • Over the past 5 years, Eastman Chemical's median Change in Account Payables value was $33.5 million (recorded in 2022), while the average stood at $26.8 million.
  • In the last 5 years, Eastman Chemical's Change in Account Payables surged by 28942.31% in 2021 and then tumbled by 101250.0% in 2023.
  • Eastman Chemical's Change in Account Payables (Quarter) stood at $177.0 million in 2021, then tumbled by 171.75% to -$127.0 million in 2022, then soared by 236.22% to $173.0 million in 2023, then decreased by 12.14% to $152.0 million in 2024, then skyrocketed by 30.92% to $199.0 million in 2025.
  • Its last three reported values are $199.0 million in Q4 2025, -$120.0 million for Q3 2025, and -$83.0 million during Q2 2025.